Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$286,040
+$43,897 QoQ
Shares Held
2,226
+10.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,375
of 1,644 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sachetta, LLC holds $1,910,793 across 12 Drug Manufacturers - General names. MRK ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,158 | $548,066 | |
| 2 | LLY |
ELI LILLY & Co
|
314 | $376,620 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,226 | $286,040 | |
| 4 | ABBV |
AbbVie Inc.
|
1,086 | $273,280 | |
| 5 | AMGN |
Amgen Inc
|
556 | $201,337 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
757 | $95,639 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
994 | $57,273 | |
| 8 | PFE |
Pfizer Inc
|
1,739 | $41,874 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,040 | 2,226 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $242,143 | 2,013 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $207,571 | 1,972 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $549,740 | 6,550 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $509,710 | 6,439 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $684,419 | 7,625 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $819,316 | 8,236 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $952,200 | 8,385 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,024,320 | 8,274 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,090,170 | 8,262 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $900,722 | 8,262 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||